Cardinal Health (NYSE:CAH) Updates FY25 Earnings Guidance

Cardinal Health (NYSE:CAH) updated its FY25 earnings guidance on Thursday. The company provided EPS guidance of at least $7.50 for the period, compared to the consensus EPS estimate of $7.89. Cardinal Health also updated its FY24 guidance to $7.30-7.40 EPS.

Cardinal Health Stock Down 4.0 %

NYSE:CAH traded down $4.07 during trading hours on Friday, hitting $98.91. 3,446,183 shares of the stock traded hands, compared to its average volume of 2,028,678. Cardinal Health has a 1 year low of $77.56 and a 1 year high of $116.04. The company has a market cap of $24.06 billion, a price-to-earnings ratio of 43.96, a price-to-earnings-growth ratio of 0.99 and a beta of 0.71. The stock has a 50 day moving average price of $109.10 and a 200 day moving average price of $105.09.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.95 by $0.13. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The business had revenue of $54.90 billion for the quarter, compared to analysts’ expectations of $56.05 billion. During the same period in the prior year, the firm earned $1.74 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts forecast that Cardinal Health will post 7.34 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were issued a $0.5006 dividend. The ex-dividend date was Thursday, March 28th. This represents a $2.00 annualized dividend and a dividend yield of 2.02%. Cardinal Health’s payout ratio is 88.89%.

Wall Street Analysts Forecast Growth

Several analysts have commented on CAH shares. Robert W. Baird decreased their price target on shares of Cardinal Health from $134.00 to $128.00 and set an outperform rating for the company in a research report on Friday. Evercore ISI boosted their target price on Cardinal Health from $110.00 to $115.00 and gave the stock an in-line rating in a research note on Friday. Argus raised Cardinal Health from a hold rating to a buy rating in a report on Friday, February 9th. Leerink Partnrs reaffirmed an outperform rating on shares of Cardinal Health in a research report on Monday, February 26th. Finally, UBS Group increased their price objective on Cardinal Health from $122.00 to $125.00 and gave the company a buy rating in a report on Monday, February 5th. One analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of Moderate Buy and a consensus price target of $105.79.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.